mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |